Bioquell plc Buy or Sell Recommendation

Macroaxis provides Bioquell plc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Bioquell plc positions. The advice algorithm takes into account all of Bioquell plc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Bioquell plc buy-and-hold prospective. Check also Bioquell plc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Bioquell plc -- USA Stock  

USD 3.5  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Bioquell plc is 'Strong Hold'.
For the selected time horizon Bioquell plc has a risk adjusted performance of 0.0, jensen alpha of 0.0, total risk alpha of 0.0, sortino ratio of 0.0 and treynor ratio of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Bioquell plc. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Bioquell plc is not overpriced, please confirm all Bioquell plc fundamentals including its Revenue, Book Value Per Share, Working Capital, as well as the relationship between Cash and Equivalents and Beta . Given that Bioquell plc has Price to Book of 2.27 times, we suggest you validate Bioquell plc market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Bioquell plc Greeks

Alpha over DOW
Beta against DOW=0.00
Overall volatility
Information ratio =0.00

Bioquell plc Volatility Alert

Bioquell plc exhibits very low volatility with skewness of 0.0 and kurtosis of 0.0. However, we advise investors to further study Bioquell plc technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Bioquell plc to competition
FundamentalsBioquell plcPeer Average
Return On Equity5.16 % (15.17) %
Return On Asset5.32 % (15.64) %
Profit Margin4.49 % (5.5) %
Operating Margin9.27 % (10.91) %
Current Valuation61.73 M152.14 B
Shares Outstanding22.25 M1.43 B
Price to Earning47.3 times40.69 times
Price to Book2.27 times14.44 times
Price to Sales2.69 times17.81 times
Revenue39.49 M9.85 B
Gross Profit12.74 M21.75 B
EBITDA5.75 M1.41 B
Net Income1.77 M517.71 M
Cash and Equivalents16.16 M3.89 B
Cash per Share0.73 times5.17 times
Debt to Equity0.01 % 0.72 %
Current Ratio3.28 times3.3 times
Book Value Per Share1.54 times13.64 times
Cash Flow from Operations9.11 M1.25 B
Earnings Per Share0.07 times2.3 times
Number of Employees22610.67 K
Market Capitalization106.1 M29.78 B
Total Asset31 M126.86 B
Retained Earnings19 M38.24 B
Working Capital13 M3.58 B
Current Asset17 M36.8 B
Current Liabilities4 M33.34 B
Z Score1.0708.73
Not Rated
Coefficient Of Variation0.0
Maximum Drawdown0.0
Potential Upside0.0